United KingdomAn estimated 88.8% of UK parents lean towards an infant RSV antibody.

Only 54.0% are firm in that intent, and RSV is a leading cause of infant hospitalisation.

Researchers surveyed 12,326 parents in August-September 2024 and modelled national intent against UK census data.

Intent ran slightly lower in London, among older parents, parents born outside the UK and some ethnic minority groups.

Telling parents the injection comes shortly after birth cut intent in the study’s randomised trial.

How each outlet framed it
Nature
distinguishes high intent (88.8% lean toward acceptance) from firm intent (54.0%); identifies implementation gaps in urban areas (especially London), older parents, non-UK-born and ethnic-minority groups

Sources: Nature